Simpson Curran's Form 4 filing
REGENXBIO Inc. (RGNX) · filed Jul 6, 2026
- Accession no.
- 0001346164-26-000006
- Filed
- Jul 6, 2026, 4:51 PM ET
- Trade date
- Dec 31, 2025-Jul 1, 2026
- Filing delay
- 187 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. It was filed 187 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simpson CurranCIK 0001346164 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Common Stock | AGrant or awardAcquired | +951 | $7.00F2 | +$6,652.72 | 343,418 | Direct | |
| Jun 30, 2026 | Common Stock | AGrant or awardAcquired | +1,453 | $10.18F4 | +$14,791.54 | 344,871 | Direct | |
| Jul 1, 2026 | Common Stock | FTax withholdingDisposed | −6,818 | $13.09 | −$89,247.62 | 338,053 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 1, 2025.
Referenced by the price of 1 transaction in Table I.
- F4
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2026.
Referenced by the price of 1 transaction in Table I.